To deepen the collaborative innovation of medicine, education, research and industry, boost scientific research, technological transformation and talent cultivation in the pharmaceutical field, and provide standardized interpretations for research project applications, the Special Training Session on Proposal Writing for Pharmaceutical Research Project Applications was successfully held in Chengdu on August 8, 2026. The event was hosted by Chengdu High-tech Medical Association and undertaken by its Hospital Pharmacy Special Committee. Pharmaceutical medical staff and core research backbones from medical institutions at all levels attended the training.

The opening ceremony was presided over by Director Zhang Peng, Chairman of the Hospital Pharmacy Special Committee of Chengdu High-tech Medical Association and from Chengdu First People’s Hospital. Ai He, person in charge of relevant divisions at Chengdu High-tech Medical Association, attended and delivered an opening address. He stated that proposal writing is a critical step for research project approval. He encouraged all participants to take this training as an opportunity to substantially improve their project application capabilities and advance high-quality development of pharmaceutical disciplines.

Centered on practical application workflows, the training delivered systematic lectures covering three core modules: research topic selection, proposal structural design, and writing skills. An interactive Q&A session was also arranged, where participants engaged in in-depth discussions with experts on specific issues including disciplinary orientation selection, research objective formulation, and the presentation ratio of pre-experimental data. The venue saw an active and lively atmosphere, realizing the expected training outcome integrating theories with real cases.

Speaker Highlights

Moderator Highlights

This training built a high-standard platform for learning and exchange among pharmaceutical researchers. It bears great significance for elevating regional pharmaceutical research capacity and advancing collaborative innovation in medicine and pharmacy.